Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Healthy Subjects
Type
Interventional
Phase
Phase 1
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 21 years and 79 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04696952
Collaborators
Not Provided
Investigators
Study Director: Taisho Director Taisho Pharmaceutical Co., Ltd.